These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8894505)

  • 1. Systemic clearance and demethylation of caffeine in sheep and cattle.
    Danielson TJ; Golsteyn LR
    Drug Metab Dispos; 1996 Oct; 24(10):1058-61. PubMed ID: 8894505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caffeine and paraxanthine HPLC assay for CYP1A2 phenotype assessment using saliva and plasma.
    Perera V; Gross AS; McLachlan AJ
    Biomed Chromatogr; 2010 Oct; 24(10):1136-44. PubMed ID: 20853468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of caffeine in plasma and saliva, and the influence of caffeine abstinence on CYP1A2 metrics.
    Perera V; Gross AS; Xu H; McLachlan AJ
    J Pharm Pharmacol; 2011 Sep; 63(9):1161-8. PubMed ID: 21827488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of pefloxacin and enoxacin with the human cytochrome P450 enzyme CYP1A2.
    Kinzig-Schippers M; Fuhr U; Zaigler M; Dammeyer J; Rüsing G; Labedzki A; Bulitta J; Sörgel F
    Clin Pharmacol Ther; 1999 Mar; 65(3):262-74. PubMed ID: 10096258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurements of caffeine and plasma metabolite/caffeine ratios as a test for hepatic drug-oxidizing capacity in goats.
    Uney K; Tumer I; Traş B
    Xenobiotica; 2011 Jul; 41(7):585-92. PubMed ID: 21476905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of a high-performance liquid chromatography assay for quantification of caffeine and paraxanthine in human serum in the context of CYP1A2 phenotyping.
    Koch JP; ten Tusscher GW; Koppe JG; Guchelaar HJ
    Biomed Chromatogr; 1999 Jun; 13(4):309-14. PubMed ID: 10416066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic activation of dacarbazine by human cytochromes P450: the role of CYP1A1, CYP1A2, and CYP2E1.
    Reid JM; Kuffel MJ; Miller JK; Rios R; Ames MM
    Clin Cancer Res; 1999 Aug; 5(8):2192-7. PubMed ID: 10473105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative pharmacokinetics of caffeine and three metabolites in clinically normal horses and donkeys.
    Peck K; Mealey KL; Matthews NS; Taylor TS
    Am J Vet Res; 1997 Aug; 58(8):881-4. PubMed ID: 9256975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the aqueous extract from Salvia miltiorrhiza Bunge on caffeine pharmacokinetics and liver microsomal CYP1A2 activity in humans and rats.
    Wang X; Yeung JH
    J Pharm Pharmacol; 2010 Aug; 62(8):1077-83. PubMed ID: 20663043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of intravenously administered caffeine in healthy alpacas (Lama pacos) and llamas (Lama glama).
    Lakritz J; Middleton JR; Anderson DE; Linden DR; Sams RA; Tessman RK; Tyler JW
    Am J Vet Res; 2006 Jun; 67(6):1063-9. PubMed ID: 16740103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of major tanshinones isolated from Danshen (Salvia miltiorrhiza) on rat CYP1A2 expression and metabolism of model CYP1A2 probe substrates.
    Wang X; Lee WY; Or PM; Yeung JH
    Phytomedicine; 2009 Aug; 16(8):712-25. PubMed ID: 19403289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of CYP1A2 in caffeine pharmacokinetics and metabolism: studies using mice deficient in CYP1A2.
    Buters JT; Tang BK; Pineau T; Gelboin HV; Kimura S; Gonzalez FJ
    Pharmacogenetics; 1996 Aug; 6(4):291-6. PubMed ID: 8873215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetics of caffeine and its metabolites theobromine, paraxanthine and theophylline after inhalation in combination with diacetylmorphine.
    Zandvliet AS; Huitema AD; de Jonge ME; den Hoed R; Sparidans RW; Hendriks VM; van den Brink W; van Ree JM; Beijnen JH
    Basic Clin Pharmacol Toxicol; 2005 Jan; 96(1):71-9. PubMed ID: 15667599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of 5-fluorouracil in mutant Nagase analbuminemic rats: faster metabolism of 5-fluorouracil via CYP1A.
    Choi YH; Bae SK; Kim SO; Lee MG
    Biopharm Drug Dispos; 2007 Mar; 28(2):87-95. PubMed ID: 17230597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A fluvoxamine-caffeine interaction study.
    Jeppesen U; Loft S; Poulsen HE; Brśen K
    Pharmacogenetics; 1996 Jun; 6(3):213-22. PubMed ID: 8807660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of antidepressant drugs on the activity of cytochrome P-450 measured by caffeine oxidation in rat liver microsomes.
    Danie WA; Syrek M; Ryłko Z; Wójcikowski J
    Pol J Pharmacol; 2001; 53(4):351-7. PubMed ID: 11990081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caffeine pharmacokinetics in preterm infants older than 2 weeks.
    Pearlman SA; Duran C; Wood MA; Maisels MJ; Berlin CM
    Dev Pharmacol Ther; 1989; 12(2):65-9. PubMed ID: 2714159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of CYP inducers and inhibitors on the pharmacokinetics of intravenous theophylline in rats: involvement of CYP1A1/2 in the formation of 1,3-DMU.
    Yang KH; Lee JH; Lee MG
    J Pharm Pharmacol; 2008 Jan; 60(1):45-53. PubMed ID: 18088504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of theophylline and caffeine after intravenous administration of aminophylline to premature neonates in Korea.
    Ahn HW; Shin WG; Park KJ; Suh OK; Choi JH
    Res Commun Mol Pathol Pharmacol; 1999; 105(1-2):105-13. PubMed ID: 10850374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of caffeine in lactating dairy cows.
    DeGraves FJ; Ruffin DC; Duran SH; Spano JS; Whatley EM; Schumacher J; Riddell MG
    Am J Vet Res; 1995 May; 56(5):619-22. PubMed ID: 7661457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.